Literature DB >> 3920705

Plasma levels of haloperidol and clinical response.

T Van Putten, S R Marder, P R May, R E Poland, R P O'Brien.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3920705

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN： 0048-5764


× No keyword cloud information.
  6 in total

1.  Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.

Authors:  M W Kelly; P J Perry; W H Coryell; D D Miller; S V Arndt
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

Review 2.  Therapeutic drug monitoring and patient outcome. A review of the issues.

Authors:  A L Tonkin; F Bochner
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

Review 3.  The relationship between serum concentration and therapeutic effect of haloperidol in patients with acute schizophrenia.

Authors:  S Ulrich; C Wurthmann; M Brosz; F P Meyer
Journal:  Clin Pharmacokinet       Date:  1998-03       Impact factor: 6.447

Review 4.  Plasma level monitoring of antipsychotic drugs. Clinical utility.

Authors:  S G Dahl
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

Review 5.  Pharmacokinetics of haloperidol.

Authors:  J S Froemming; Y W Lam; M W Jann; C M Davis
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

6.  Clinical considerations on neuroleptic malignant syndrome.

Authors:  G B Palermo
Journal:  J R Soc Med       Date:  1991-08       Impact factor: 18.000
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.